(ESRD) occur after lung transplantation. 4, 7 This analysis aims to explore the incidence and outcomes of kidney transplantation in previous lung recipients (kidney after lung [KAL] ). Authors assess recipient and renal allograft outcomes to determine whether transplantation in this population (KAL) is associated with appropriate longevity when compared with recipients of primary, kidney-only transplantation (KTx).
| MATERIALS AND METHODS

| Institutional review
The protocol for the retrospective analysis was approved by the Institutional Review Board at Duke University Medical Center, Durham, NC. Individual consent was not required.
| Data source
The United Network for Organ Sharing (UNOS) national database contains data on all transplantation procedures performed in the United 
| Study design and patient selection
All patients undergoing kidney and lung transplantations within the study dates were considered for inclusion in the study. Exclusion criteria included age less than 18 years, non-primary transplantation, simultaneous multi-organ transplantation (including concurrent lung-kidney transplantation), or kidney transplant prior to lung transplantation. Following exclusions, records from the lung and kidney transplantation databases were cross-matched to identify patients with a history of lung transplantation who were subsequently listed for kidney transplantation. The final study cohort was made up of lung recipients who ultimately underwent kidney transplantation (KAL [ Figure 1] ).
| Propensity matching
To analyze outcomes in the KAL cohort, KAL patients were matched 1:2 with recipients of primary, kidney only transplantation (KTx) based on the propensity score method as outlined by Rosenbaum and Rubin, D'Agostino and Rubin, and Austin. [8] [9] [10] [11] Using a logistic regression model with covariate selection based on backward elimination, we calculated a propensity score for each patient, which represents the "risk" of being a KAL recipient. Our model controlled for differences in age, race, gender, body mass index (BMI), etiology of renal disease, functional status, and type of kidney donor (living vs deceased) between KAL and KTx cohorts. Each KAL recipient was subsequently matched with two KTx patients to create the 1:2 matched cohort for analysis of outcomes.
Per convention for managing missing data in propensity score analysis, a value of 0 was imputed in empty fields for continuous variables with creation of a new, binary variable indicating those records that have missing entries. For categorical variables, an additional level was created for missing data. 10, 12, 13 Comparisons between cohorts were made using standardized differences with values less than 0.2, indicating negligible differences in a given patient characteristic.
14,15 
| Primary analysis
| Secondary analysis
Secondary analyses used multivariable Cox-regression models to explore predictors of improved outcomes in KAL cohorts. Additionally, we compared outcomes in primary, lung-only recipients (LTx) with an aggregated cohort of KAL recipients and lung recipients who were listed for kidneys but did not receive them. Analyses were performed using time-dependent Cox-regression models that explored implications of going-on dialysis and of undergoing kidney transplantation on outcomes in patients with a history of lung transplantation.
| Statistical analysis
Statistical analyses were performed using SAS v9.3 (SAS Institute
Inc., Cary, NC, USA). Variables in propensity-matched analysis were compared with standardized differences as previously described.
For non-matched comparisons, continuous variables were compared using the Student's t-test while categorical variables were compared using the chi-square statistic. Survival analyses were performed using Kaplan-Meier and Cox regression analyses as described. Variables were included in multivariable models if they had P value <.2 on univariate or bivariate analysis. Final multivariable models were determined using a backward selection algorithm.
Per convention, the threshold for statistical significance of analyses was set at <.05. Variables were included in analyses if they were at least 80% populated, with most having complete data for more than 95% of patients included in the study.
| RESULTS
| Patient characteristics
Of 20 572 lung recipients who met study criteria, 616 (2.9%) were subsequently listed for kidney transplantation; 270 of these patients (1.3%) ultimately underwent kidney transplantation ( Figure 1 ). Within the group of patients who were listed for and/or underwent kidney transplantation, there were some differences in populations that ultimately received kidneys (KAL) compared with those on the waitlist who did not undergo renal transplantation. KAL patients were on average younger (median age, 53 vs 58 years at the time of listing [or at kidney transplantation for recipients of living donor transplantation who were never listed], P<.0001), less likely to already be on dialysis (41.4% vs 56.1%, P = .0009), more likely to be Caucasian (94.8% vs 87.3%, P = .0015), and more likely to have undergone lung transplantation for a diagnosis of cystic fibrosis/bronchiectasis (38.5% vs 25.4%, P = .0004 [ Table 2 ]). Median time between lung transplantation and listing for kidneys was similar in the two groups (82 vs 76 months, P = .3191), as was median time between lung transplantation and initiation of HD (83 vs 68 months, P = .1109).
| Primary analysis
Univariate time-dependent Cox regression models comparing KAL patients with lung recipients listed for kidney transplantation who never T A B L E 2 Characteristics of lung recipients who underwent kidney transplantation compared to those listed for kidney transplantation who did not ultimately receive organs P<.0001 [ Figure 2] ). Similarly, the risk of graft loss was higher for KAL patients (HR, 1.96; 95% CI, 1.57-2.46; P = .0317 [ Figure 3A] ).
Additional Cox regression models exploring comparative deathcensored graft survival demonstrated no significant differences between the two groups (HR, 1.05; 95% CI, 0.63-1.75; P = .8586
[ Figure 3B] ).
| Secondary analysis
Cox regression models were created to identify factors associated with improved survival following kidney transplantation in patients with a prior history of lung transplantation (ie, KAL patients).
Univariate Notably, both of the models described in this paragraph were set up such that survival time prior to dialysis or kidney transplantation was appropriately attributed to the LTx group. In other words, survival of KAL patients prior to kidney transplantation was classified as LTx survival trying to mitigate the effects of lead time bias.
| COMMENT
Renal insufficiency is not uncommon after lung transplantation, likely related to the widespread use of nephrotoxic calcineurin inhibition regimen post-transplantation. 5, 7 This study represents the first dedicated analysis of the national experience with kidney transplantation in lung recipients (KAL). Our analysis suggests that renal transplantation in patients with a history of prior lung transplantation confers significant survival benefit when compared with waitlisting for ESRD without subsequent receipt of a kidney allograft. However, renal transplantation in patients with a prior history of lung transplantation T A B L E 4 Characteristics of kidney after lung recipients compared with risk matched patients undergoing primary, kidney only transplantation with no prior history of lung transplantation Although excluded from our analysis, there were 18 simultaneous lung-kidney transplants performed within the study dates and this remains an option for patients. However, the relative infrequency of this occurrence is likely related to traditional descriptions of ESRD-which would represent "significant dysfunction in another organ system"-as a contra-indication to lung transplantation. Further supporting this hypothesis is the fact that only 0.23% of patients were on dialysis at the time of lung transplantation.
Our results comparing KAL patients to those who underwent primary, lung-only transplantation provide further evidence of the survival benefit of kidney transplantation in this population, as KAL patients enjoy improved longevity compared with lung-only recipients. given lung recipient will allow for use of extended criteria organs in this population to minimize the controversy associated with maintained kidney allograft function at the time of death. It will be important, however, to carefully balance risks so that kidney graft loss does not then become the cause of mortality in KAL patients. This is not too unlike current efforts to provide ideal organs for high-risk primary kidneyonly recipients, particularly those with advanced age; (ii) benefits of living vs deceased donor kidney transplantation for KAL patients are seen in improved graft survival, but also in the logistics of organ allocation as there is somewhat less direct competition with the overall kidney candidate pool as living donors are very often related to recipients. In this setting, the key will be to educate donors about the intricacies of living donation to a KAL patient as previously outlined; and (iii) worse outcomes for lung recipients on the waitlist for kidneys highlight the detrimental effect of ESRD to lung allografts and hint at the benefit of early discussion about options for renal replacement when ESRD is imminent. This will allow recipients and practitioners to evaluate options early and receive kidneys early on in the progression of their disease.
Our study is limited by its retrospective design, which exposes it to the shortcomings associated with non-prospective, non-randomized analyses. Notably, results could be a reflection of confounding based on variables that have not been controlled for, which should be acknowledged when interpreting our findings. Additionally, we recognize that analyses using large data repositories like the UNOS database are fraught with uncertainties related to the completeness and accuracy of available data. For this analysis, all included variables were robustly populated, mitigating this limitation to some degree. A final limitation is found in our consideration of the interplay between renal dysfunction and waitlist outcomes. A considerable proportion of KAL patients underwent living donor renal transplantation and thus were never put on the kidney waitlist. This imposes some limitation in our understanding of time to and circumstances surrounding development of severe kidney disease following lung transplantation.
| CONCLUSION
Lung recipients who subsequently undergo kidney transplantation enjoy a significant survival benefit when compared with lung recipients who are waitlisted but do not end up receiving kidneys. However, 
